Literature DB >> 2571143

Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man.

P Turner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571143      PMCID: PMC2429145          DOI: 10.1136/pgmj.65.759.1

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  49 in total

1.  The treatment of tranquilizer dependence by propranolol.

Authors:  C Hallström; G Crouch; M Robson; P Shine
Journal:  Postgrad Med J       Date:  1988       Impact factor: 2.401

Review 2.  The treatment of anxiety with beta-blocking drugs.

Authors:  M Peet
Journal:  Postgrad Med J       Date:  1988       Impact factor: 2.401

3.  Stroke in migraine as a consequence of propranolol.

Authors:  A Bardwell; J A Trott
Journal:  Headache       Date:  1987-07       Impact factor: 5.887

4.  The comparative effects of ICI 118551 and propranolol on essential tremor.

Authors:  D Jefferson; H J Wharrad; A T Birmingham; J M Patrick
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

5.  Beta-blockers and mental performance.

Authors:  E D Frohlich
Journal:  Arch Intern Med       Date:  1988-04

6.  The effect of propranolol on anxiety.

Authors:  K L Granville-Grossman; P Turner
Journal:  Lancet       Date:  1966-04-09       Impact factor: 79.321

7.  A double-blind placebo controlled trial of a selective beta 2 adrenoceptor antagonist (ICI 118551) in chronic anxiety.

Authors:  D J King; N M Devaney; J K Gilbert
Journal:  Int Clin Psychopharmacol       Date:  1987-07       Impact factor: 1.659

8.  Psychosis with propranolol: still not recognized?

Authors:  J G Cunnane; G W Blackwood
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

9.  The effect of beta-blockers on mental performance on older hypertensive patients.

Authors:  F M Gengo; S C Fagan; A de Padova; J K Miller; P R Kinkel
Journal:  Arch Intern Med       Date:  1988-04

10.  Is there a central nervous withdrawal syndrome associated with discontinuing long-term treatment with propranolol?

Authors:  H al-Qassab; L A Cleeves; P L Francis; M R al-Sereiti; L Findley; A Hedges; R Silman; P Turner
Journal:  Hum Toxicol       Date:  1988-05
View more
  2 in total

Review 1.  Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.

Authors:  Jillian G Baker; Stephen J Hill; Roger J Summers
Journal:  Trends Pharmacol Sci       Date:  2011-03-21       Impact factor: 14.819

Review 2.  Which ancillary properties of beta-adrenoceptor blocking drugs influence their therapeutic or adverse effects?: a review.

Authors:  P Turner
Journal:  J R Soc Med       Date:  1991-11       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.